1-4 of 4
Anna Klukowska, MD
Close
Sort by
Journal Articles

Immune Tolerance Induction (ITI) in Paediatric and Adult Patients with Haemophilia a (HA) and High-Titre (HT) Factor VIII (FVIII) Inhibitor - Real Life Data

Magdalena Katarzyna Letowska, Krystyna Zawilska, MD PhD, Anna Klukowska, MD PhD, Krzysztof Chojnowski, MD PhD, Joanna Zdziarska, MD PhD, Ewa Stefanska-Windyga, MD PhD, Jerzy Windyga
Journal: Blood
Blood (2019) 134 (Supplement_1): 4942.
https://doi.org/10.1182/blood-2019-122422
Published: 2019
Journal Articles

The PUP-GCP Clinical Trial: A Low Inhibitor Rate in Previously Untreated Patients with Severe Hemophilia a Treated with Octanate

Sigurd Knaub, PhD, Anna Klukowska, MD, Vladimir Komrska, Pawel Laguna, MD PhD, Vdovin Vladimir, MD, Martina Jansen
Journal: Blood
Blood (2014) 124 (21): 5051.
https://doi.org/10.1182/blood.V124.21.5051.5051
Published: 2014
Journal Articles

The Assessment of Risk Factors for Thrombosis in Children Treated for Non- Hodgkin Lymphoma

Katarzyna Smalisz-Skrzypczyk, Anna Klukowska, MD, Iwona Malinowska, MD PhD, Agata Sobocinska-Mirska, Michal Romiszewski, Michal Matysiak, Prof.
Journal: Blood
Blood (2014) 124 (21): 5460.
https://doi.org/10.1182/blood.V124.21.5460.5460
Published: 2014
Journal Articles

Tracking Factor VIII-Specific Memory B Cells in Hemophilia A Patients with Factor VIII Inhibitors.

Irene Lang, Jerzy Windyga, MD, Anna Klukowska, MD, Josenato Ilas, Hans Peter Schwarz, MD, Birgit M. Reipert, PhD
Journal: Blood
Blood (2006) 108 (11): 1016.
https://doi.org/10.1182/blood.V108.11.1016.1016
Published: 2006